{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Agenus", "item": "https://www.patentleaderboard.com/2021/company/agenus"}, {"@type": "ListItem", "position": 4, "name": "Hao Tang", "item": "https://www.patentleaderboard.com/2021/inventor/fl:ha_ln:tang-78"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
HT

Hao Tang — 5 Patents in 2021

AGAgenus: 1 patents #18 of 29Top 65%
LRLudwig Institute For Cancer Research: 1 patents #14 of 37Top 40%
MCMemorial Sloan Kettering Cancer Center: 1 patents #47 of 231Top 25%
UNUnknown: 1 patents #344 of 3,329Top 15%
Lexington, MA: #30 of 469 inventorsTop 7%
Massachusetts: #568 of 14,123 inventorsTop 5%
Overall (2021): #32,960 of 548,734Top 7%
5 Patents 2021

Issued Patents 2021

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11136404 Anti-OX40 antibodies Marc van Dijk, Ekaterina V. Breous-Nystrom, Volker Seibert, Gerd Ritter, David Schaer +5 more 2021-10-05 $20,506,000
11137395 SARS-CoV-2 (COVID-19) spike-AXL binding assay Ruo-Pan Huang, Tuhin Das, Shuhong Luo, Jianmin Fang 2021-10-05
11105804 COVID-19 spike-ACE2 binding assay for drug and antibody screening Ruo-Pan Huang, Shuhong Luo, Jianmin Fang 2021-08-31
11053317 Pharmaceutical preparation stably comprising CD147 monoclonal antibody Qiang Feng, Xiaochun Chen 2021-07-06
11027016 Pharmaceutical preparation stably comprising CD147 monoclonal antibody Qiang Feng, Tianyi Yang, Mingxi Chen 2021-06-08